Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Moderna, Inc. (MRNA) vs Tempus AI (TEM) Price & Performance

Moderna, Inc.Trade
Tempus AITrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Tempus AI — how do they compare? Moderna, Inc. trades at $59.68 (market cap $23.60B), while Tempus AI trades at $49 (market cap $8.69B). The key difference: Moderna, Inc. is far larger — about 2.7× Tempus AI's market cap, and Moderna, Inc. is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.

MRNATEM
Market Cap
$23.60B$8.69B
Sector
HealthBroad Market / Factor
52-Week High
$81.80$103.25
52-Week Low
$22.36$42.37
Enterprise Value
$19.70B$9.37B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM